VANSEN PHARMA INC. Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31)
VANSEN PHARMA INC. reported Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) of $0.3 for the 12-month period ending 2012-12-31, per its 10-K filed 2013-04-12.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EquityIssuancePerShareAmount · last filed 2013-04-12
- VANSEN PHARMA INC. development stage entities, equity issuance, per share amount (deprecated 2015-01-31) for fiscal 2012 was $0.30, a 0.00% change from fiscal 2011.
- VANSEN PHARMA INC. development stage entities, equity issuance, per share amount (deprecated 2015-01-31) for fiscal 2011 was $0.30.
| Period end | Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) 12 month |
|---|---|
| 2012-12-31 | $0.30 10-K · filed 2013-04-12 |
| 2011-12-31 | $0.30 10-K · filed 2013-04-12 |